Literature DB >> 18458767

The assessment of cognitive impairment would be a relevant addition to the criteria for diagnosing schizophrenia.

Hans-Jürgen Möller1.   

Abstract

Entities:  

Year:  2008        PMID： 18458767      PMCID： PMC2327225          DOI： 10.1002/j.2051-5545.2008.tb00148.x

Source DB:  PubMed          Journal:  World Psychiatry        ISSN： 1723-8617            Impact factor:   49.548


× No keyword cloud information.
  7 in total

Review 1.  Definition, psychopharmacological basis and clinical evaluation of novel/atypical neuroleptics: methodological issues and clinical consequences.

Authors:  H J Möller
Journal:  World J Biol Psychiatry       Date:  2000-04       Impact factor: 4.132

2.  M129V variation in the prion protein may influence cognitive performance.

Authors:  D Rujescu; A M Hartmann; C Gonnermann; H-J Möller; I Giegling
Journal:  Mol Psychiatry       Date:  2003-11       Impact factor: 15.992

3.  A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia.

Authors:  Robert W Buchanan; Miriam Davis; Donald Goff; Michael F Green; Richard S E Keefe; Andrew C Leon; Keith H Nuechterlein; Thomas Laughren; Robert Levin; Ellen Stover; Wayne Fenton; Steve R Marder
Journal:  Schizophr Bull       Date:  2005-02-16       Impact factor: 9.306

Review 4.  Problems associated with the classification and diagnosis of psychiatric disorders.

Authors:  Hans-Jürgen Möller
Journal:  World J Biol Psychiatry       Date:  2005       Impact factor: 4.132

Review 5.  Intermediate phenotypes and genetic mechanisms of psychiatric disorders.

Authors:  Andreas Meyer-Lindenberg; Daniel R Weinberger
Journal:  Nat Rev Neurosci       Date:  2006-10       Impact factor: 34.870

6.  Plexin B3 is genetically associated with verbal performance and white matter volume in human brain.

Authors:  D Rujescu; E M Meisenzahl; S Krejcova; I Giegling; T Zetzsche; M Reiser; C M Born; H-J Möller; A Veske; A Gal; U Finckh
Journal:  Mol Psychiatry       Date:  2006-10-10       Impact factor: 15.992

7.  [Negative symptoms of schizophrenic patients from the perspective of psychiatrists, patients themselves and their relatives].

Authors:  R Bottlender; M Jäger; I Kunze; C Groll; I Borski; H-J Möller
Journal:  Nervenarzt       Date:  2003-09       Impact factor: 1.214
  7 in total
  2 in total

Review 1.  The forthcoming revision of the diagnostic and classificatory system: perspectives based on the European psychiatric tradition.

Authors:  Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-11       Impact factor: 5.270

Review 2.  Systematic of psychiatric disorders between categorical and dimensional approaches: Kraepelin's dichotomy and beyond.

Authors:  Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-06       Impact factor: 5.270
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.